Background. Depolarizing (hyperkalemic) solutions impair the coronary
endothelial function through an endothelium-derived hyperpolarizing fa
ctor mechanism, I examined the hypothesis that potassium-channel opene
rs may restore the impaired endothelium-derived hyperpolarizing factor
-mediated coronary vasorelaxation when added to hyperkalemic cardiople
gia. Methods. The porcine coronary arteries were exposed to hyperkalem
ia (potassium, 20 or 50 mmol/L) or hyperkalemia plus the potassium-cha
nnel opener aprikalim at 0.1 mmo/L for 1 hour. Endothelium-derived hyp
erpolarizing factor-mediated relaxation (percentage of 30 nmol/L U4661
9 precontraction) was induced by calcium ionophore A23187 and bradykin
in in the presence of indomethacin (7 mu mol/L) and N omega-nitro-L-ar
ginine (300 mu mol/L). Results. The endothelium-derived hyperpolarizin
g factor-mediated relaxation was significantly impaired by exposure to
hyperkalemia (20 mmol/L: 24.9% +/- 14.1% versus 88.0% +/- 3.3% in con
trol, p = 0.002 for A23187; 50 mmol/L: 40.5% +/- 12.3% versus 76.5% +/
- 3.8%, p = 0.003 for bradykinin). This reduced relaxation was signifi
cantly recovered by addition of aprikalim into the hyperkalemic (20 mm
ol/L) solution in A23187 experiments (81.2% +/- 4.8%, p = 0.002) but o
nly slightly recovered when added into the higher concentration of pot
assium (50 mmol/L) in bradykinin experiments (56.1% +/- 4.7%, p = 0.2)
. Conclusions. Potassium-channel openers may preserve endothelium-deri
ved hyperpolarizing factor-mediated coronary relaxation when added to
traditional hyperkalemic cardioplegia. This effect is significant when
the potassium concentration is 20 mmol/L but partially lost when it r
eaches 50 mmol/L. This study may provide new insights into cardioprote
ction during open heart operations. (Ann Thorac Surg 1998;66:1318-22)
(C) 1998 by The Society of Thoracic Surgeons